| Trial ID: | L2662 |
| Source ID: | NCT01984489
|
| Associated Drug: |
Placebo
|
| Title: |
Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Placebo|DRUG: SHR117887
|
| Outcome Measures: |
Primary: Change From Baseline in HbA1c (Hemoglobin A1C) at Week 12, 12 weeks | Secondary: Percentage of Participants Achieving Less Than (<) 6.5% or <7% HbA1c Levels, 12 weeks|Change From Baseline in Fasting Plasma Glucose,insulin and C-peptide at Week 12, 12 weeks|Post-meal total and incremental glucose,insulin and C-peptide area under the curve at week 12, 12 weeks|Change From Baseline in Body Weight at Week 12, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-06
|
| Completion Date: |
2013-08
|
| Results First Posted: |
|
| Last Update Posted: |
2013-11-19
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01984489
|
